Emotional Needs of Caregivers and Patient/Spouse Couples During Hematopoietic Stem Cell Transplantation (HSCT)
Data Collection
Congenital Abnormalities+99
+ Carcinoma, Ovarian Epithelial
+ Urogenital Diseases
Summary
Study start date: March 1, 2002
Actual date on which the first participant was enrolled.OBJECTIVES: * Assess expression of emotion, as a function of patient presence, among spousal or other cohabiting caregivers (CG) of post-hematopoietic stem cell transplantation patients. * Assess desynchrony among subjective (self-report) and expressive indicators of emotion, as a function of patient presence, in these participants. * Correlate CG dispositional inhibition and desynchrony with physical and marital satisfaction in these participants. OUTLINE: Caregivers (CG) complete written questionnaires assessing demographics, positive and negative affect, dispositional inhibition, marital satisfaction, and physical health over 45 minutes to 1 hour on day 1. CG then engage in two oral emotional expression exercises (on the topic of caregiving and the transplant) over 2 hours on day 2. Patients are present for one oral emotional expression exercise. Participants are followed at 2 weeks and 6 months. PROJECTED ACCRUAL: A total of 60 patient/spouse couples will be accrued for this study within 18 months.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 21 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
DISEASE CHARACTERISTICS: * In a marriage OR long-term, committed, heterosexual or homosexual, cohabiting relationship in which one member is post-hematopoietic stem cell transplantation * Patients must meet the following criteria: * At least 1 year since prior first bone marrow, stem cell, or umbilical cord blood transplantation * Allogeneic or autologous * Diagnosis of malignancy, myelodysplasia, or non-malignancy * No indication of possible or confirmed relapse * Spouse/caregiver (CG) must meet the following criteria: * Serve as the primary CG to the patient * No prior or concurrent neurologic disorder PATIENT CHARACTERISTICS: Age * 21 and over Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * No concurrent major psychiatric disorder * English-speaking PRIOR CONCURRENT THERAPY: Biologic therapy * See Disease Characteristics Chemotherapy * Not specified Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * Not specified
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Fred Hutchinson Cancer Research Center
Seattle, United StatesOpen Fred Hutchinson Cancer Research Center in Google Maps